BRAINSTORM CELL THERAPEUTICS INC. Research and Development Expense
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Research and Development Expense of $963.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for the quarter ending 2026-06-30 was $963.00K, a 14.02% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for the quarter ending 2026-03-31 was $762.00K, a 41.56% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for the quarter ending 2025-12-31 was $852.00K, a 50.55% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for the quarter ending 2025-09-30 was $899.00K, a 13.97% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for fiscal 2025 was $4.17M, a 10.23% decline from fiscal 2024.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for fiscal 2024 was $4.65M, a 56.72% decline from fiscal 2023.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for fiscal 2023 was $10.75M, a 23.00% decline from fiscal 2022.
- BRAINSTORM CELL THERAPEUTICS INC. research and development expense for fiscal 2022 was $13.96M, a 8.40% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 129 month | Research and Development Expense 132 month | Research and Development Expense 135 month | Research and Development Expense 138 month | Research and Development Expense 141 month | Research and Development Expense 144 month | Research and Development Expense 147 month | Research and Development Expense 150 month | Research and Development Expense 153 month | Research and Development Expense 156 month | Research and Development Expense 159 month | Research and Development Expense 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $963.00K 10-Q · filed 2026-08-14 | $1.73M 10-Q · filed 2026-08-14 | $2.58M derived: sum of 3 quarters · filed 2026-08-14 | $3.48M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2026-03-31 | $762.00K 10-Q · filed 2026-05-15 | $1.61M derived: sum of 2 quarters · filed 2026-05-15 | $2.51M derived: sum of 3 quarters · filed 2026-05-15 | $3.63M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.75M derived: sum of 2 quarters · filed 2026-03-31 | $2.87M derived: sum of 3 quarters · filed 2026-08-14 | $4.17M 10-K · filed 2026-03-31 | ||||||||||||||
| 2025-09-30 | $899.00K 10-Q · filed 2025-11-14 | $2.02M derived: sum of 2 quarters · filed 2026-08-14 | $3.32M 10-Q · filed 2025-11-14 | $5.05M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-06-30 | $1.12M 10-Q · filed 2026-08-14 | $2.42M 10-Q · filed 2026-08-14 | $4.15M derived: sum of 3 quarters · filed 2026-08-14 | $5.19M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-03-31 | $1.30M 10-Q · filed 2026-05-15 | $3.03M derived: sum of 2 quarters · filed 2026-05-15 | $4.07M derived: sum of 3 quarters · filed 2026-05-15 | $4.99M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||||
| 2024-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.77M derived: sum of 2 quarters · filed 2026-03-31 | $3.69M derived: sum of 3 quarters · filed 2026-03-31 | $4.65M 10-K · filed 2026-03-31 | ||||||||||||||
| 2024-09-30 | $1.04M 10-Q · filed 2025-11-14 | $1.97M derived: sum of 2 quarters · filed 2025-11-14 | $2.93M 10-Q · filed 2025-11-14 | $4.63M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||||
| 2024-06-30 | $922.00K 10-Q · filed 2025-08-14 | $1.88M 10-Q · filed 2025-08-14 | $3.58M derived: sum of 3 quarters · filed 2025-08-14 | $6.91M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||
| 2024-03-31 | $961.00K 10-Q · filed 2025-05-15 | $2.66M derived: sum of 2 quarters · filed 2025-05-15 | $5.99M derived: sum of 3 quarters · filed 2025-05-15 | $8.78M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||
| 2023-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.03M derived: sum of 2 quarters · filed 2025-03-31 | $7.82M derived: sum of 3 quarters · filed 2025-03-31 | $10.75M 10-K · filed 2025-03-31 | ||||||||||||||
| 2023-09-30 | $3.33M 10-Q · filed 2024-11-14 | $6.12M derived: sum of 2 quarters · filed 2024-11-14 | $9.05M 10-Q · filed 2024-11-14 | $11.50M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||
| 2023-06-30 | $2.79M 10-Q · filed 2024-08-14 | $5.72M 10-Q · filed 2024-08-14 | $8.17M derived: sum of 3 quarters · filed 2024-08-14 | $11.95M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||
| 2023-03-31 | $2.92M 10-Q · filed 2024-05-14 | $5.38M derived: sum of 2 quarters · filed 2024-05-14 | $9.15M derived: sum of 3 quarters · filed 2024-05-14 | $14.26M derived: sum of 4 quarters · filed 2024-05-14 | ||||||||||||||
| 2022-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $6.23M derived: sum of 2 quarters · filed 2024-04-01 | $11.34M derived: sum of 3 quarters · filed 2024-04-01 | $13.96M 10-K · filed 2024-04-01 | ||||||||||||||
| 2022-09-30 | $3.78M 10-Q · filed 2023-11-14 | $8.89M derived: sum of 2 quarters · filed 2023-11-14 | $11.51M 10-Q · filed 2023-11-14 | $15.18M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||||
| 2022-06-30 | $5.11M 10-Q · filed 2023-08-14 | $7.73M 10-Q · filed 2023-08-14 | $11.41M derived: sum of 3 quarters · filed 2023-08-14 | $15.02M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||||
| 2022-03-31 | $2.62M 10-Q · filed 2023-05-15 | $6.29M derived: sum of 2 quarters · filed 2023-05-15 | $9.91M derived: sum of 3 quarters · filed 2023-05-15 | $13.51M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||||
| 2021-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $7.29M derived: sum of 2 quarters · filed 2023-03-30 | $10.89M derived: sum of 3 quarters · filed 2023-03-30 | $15.23M 10-K · filed 2023-03-30 | ||||||||||||||
| 2021-09-30 | $3.62M 10-Q · filed 2022-11-14 | $7.22M derived: sum of 2 quarters · filed 2022-11-14 | $11.56M 10-Q · filed 2022-11-14 | $20.38M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||
| 2021-06-30 | $3.60M 10-Q · filed 2022-08-15 | $7.94M 10-Q · filed 2022-08-15 | $16.76M derived: sum of 3 quarters · filed 2022-08-15 | $18.63M derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||||
| 2021-03-31 | $4.34M 10-Q · filed 2022-05-16 | $13.16M derived: sum of 2 quarters · filed 2022-05-16 | $15.03M derived: sum of 3 quarters · filed 2022-05-16 | $20.72M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||||
| 2020-12-31 | $8.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $10.69M derived: sum of 2 quarters · filed 2022-03-28 | $16.38M derived: sum of 3 quarters · filed 2022-03-28 | $22.33M 10-K · filed 2022-03-28 | ||||||||||||||
| 2020-09-30 | $1.87M 10-Q · filed 2021-11-15 | $7.56M derived: sum of 2 quarters · filed 2021-11-15 | $13.51M 10-Q · filed 2021-11-15 | $19.70M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | $5.69M 10-Q · filed 2021-08-05 | $11.64M 10-Q · filed 2021-08-05 | $17.83M derived: sum of 3 quarters · filed 2021-08-05 | $21.84M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||||
| 2020-03-31 | $5.95M 10-Q · filed 2021-04-26 | $12.13M derived: sum of 2 quarters · filed 2021-04-26 | $16.14M derived: sum of 3 quarters · filed 2021-04-26 | $19.70M derived: sum of 4 quarters · filed 2021-04-26 | ||||||||||||||
| 2019-12-31 | $6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-04 | $10.19M derived: sum of 2 quarters · filed 2021-02-04 | $13.75M derived: sum of 3 quarters · filed 2021-02-04 | $17.20M 10-K · filed 2021-02-04 | ||||||||||||||
| 2019-09-30 | $4.01M 10-Q · filed 2020-10-15 | $7.56M derived: sum of 2 quarters · filed 2020-10-15 | $11.02M 10-Q · filed 2020-10-15 | $14.88M derived: sum of 4 quarters · filed 2020-10-15 | ||||||||||||||
| 2019-06-30 | $3.55M 10-Q · filed 2020-08-05 | $7.01M 10-Q · filed 2020-08-05 | $10.87M derived: sum of 3 quarters · filed 2020-08-05 | $12.85M derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | $3.46M 10-Q · filed 2020-05-07 | $7.32M derived: sum of 2 quarters · filed 2020-05-07 | $9.29M derived: sum of 3 quarters · filed 2020-05-07 | $10.77M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||
| 2018-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $5.83M derived: sum of 2 quarters · filed 2020-02-18 | $7.32M derived: sum of 3 quarters · filed 2020-02-18 | $8.29M 10-K · filed 2020-02-18 | ||||||||||||||
| 2018-09-30 | $1.98M 10-Q · filed 2019-11-14 | $3.46M derived: sum of 2 quarters · filed 2019-11-14 | $4.43M 10-Q · filed 2019-11-14 | $2.87M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||||||||
| 2018-06-30 | $1.48M 10-Q · filed 2019-08-13 | $2.46M 10-Q · filed 2019-08-13 | $891.00K derived: sum of 3 quarters · filed 2019-08-13 | $2.06M derived: sum of 4 quarters · filed 2019-08-13 | ||||||||||||||
| 2018-03-31 | $977.00K 10-Q · filed 2019-05-10 | -$590.00K derived: sum of 2 quarters · filed 2019-05-10 | $578.00K derived: sum of 3 quarters · filed 2019-05-10 | $1.01M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||||
| 2017-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$399.00K derived: sum of 2 quarters · filed 2019-04-01 | $36.00K derived: sum of 3 quarters · filed 2019-04-01 | $977.00K 10-K · filed 2019-04-01 | ||||||||||||||
| 2017-09-30 | $1.17M 10-Q · filed 2018-10-29 | $1.60M derived: sum of 2 quarters · filed 2018-10-29 | $2.54M 10-Q · filed 2018-10-29 | $2.87M derived: sum of 4 quarters · filed 2018-10-29 | ||||||||||||||
| 2017-06-30 | $435.00K 10-Q · filed 2018-07-23 | $1.38M 10-Q · filed 2018-07-23 | $1.70M derived: sum of 3 quarters · filed 2018-07-23 | $2.49M derived: sum of 4 quarters · filed 2018-07-23 | ||||||||||||||
| 2017-03-31 | $941.00K 10-Q · filed 2018-05-14 | $1.26M derived: sum of 2 quarters · filed 2018-05-14 | $2.05M derived: sum of 3 quarters · filed 2018-05-14 | $2.21M derived: sum of 4 quarters · filed 2018-05-14 | ||||||||||||||
| 2016-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.11M derived: sum of 2 quarters · filed 2018-03-08 | $1.26M derived: sum of 3 quarters · filed 2018-03-08 | $2.25M 10-K · filed 2018-03-08 | ||||||||||||||
| 2016-09-30 | $790.00K 10-Q · filed 2017-10-17 | $941.00K derived: sum of 2 quarters · filed 2017-10-17 | $1.93M 10-Q · filed 2017-10-17 | $2.75M derived: sum of 4 quarters · filed 2017-10-17 | ||||||||||||||
| 2016-06-30 | $151.00K 10-Q · filed 2017-08-14 | $1.14M 10-Q · filed 2017-08-14 | $1.96M derived: sum of 3 quarters · filed 2017-08-14 | $3.47M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||||
| 2016-03-31 | $986.00K 10-Q · filed 2017-05-15 | $1.81M derived: sum of 2 quarters · filed 2017-05-15 | $3.31M derived: sum of 3 quarters · filed 2017-05-15 | $4.69M derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||||
| 2015-12-31 | $826.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $2.33M derived: sum of 2 quarters · filed 2017-03-29 | $3.70M derived: sum of 3 quarters · filed 2017-03-29 | $4.95M 10-K · filed 2017-03-29 | ||||||||||||||
| 2015-09-30 | $1.50M 10-Q · filed 2016-11-14 | $2.88M derived: sum of 2 quarters · filed 2016-11-14 | $4.12M 10-Q · filed 2016-11-14 | $5.77M derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||||
| 2015-06-30 | $1.38M 10-Q · filed 2016-08-11 | $2.62M 10-Q · filed 2016-08-11 | $4.26M derived: sum of 3 quarters · filed 2016-08-11 | $5.83M derived: sum of 4 quarters · filed 2016-08-11 | ||||||||||||||
| 2015-03-31 | $1.25M 10-Q · filed 2016-05-10 | $2.89M derived: sum of 2 quarters · filed 2016-05-10 | $4.46M derived: sum of 3 quarters · filed 2016-05-10 | $5.34M derived: sum of 4 quarters · filed 2016-05-10 | ||||||||||||||
| 2014-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $3.21M derived: sum of 2 quarters · filed 2016-03-09 | $4.09M derived: sum of 3 quarters · filed 2016-03-09 | $4.77M 10-K · filed 2016-03-09 | ||||||||||||||
| 2014-09-30 | $1.57M 10-Q · filed 2015-11-16 | $2.45M derived: sum of 2 quarters · filed 2015-11-16 | $3.13M 10-Q · filed 2015-11-16 | $3.98M derived: sum of 4 quarters · filed 2015-11-16 | ||||||||||||||
| 2014-06-30 | $877.00K 10-Q · filed 2015-08-13 | $1.56M 10-Q · filed 2015-08-13 | $2.41M derived: sum of 3 quarters · filed 2015-08-13 | $3.21M derived: sum of 4 quarters · filed 2015-08-13 | ||||||||||||||
| 2014-03-31 | $680.00K 10-Q · filed 2015-05-14 | $1.53M derived: sum of 2 quarters · filed 2015-05-14 | $2.33M derived: sum of 3 quarters · filed 2015-05-14 | $3.08M derived: sum of 4 quarters · filed 2015-05-14 | $29.79M 10-Q · filed 2014-05-13 | |||||||||||||
| 2013-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $1.65M derived: sum of 2 quarters · filed 2015-03-26 | $2.40M derived: sum of 3 quarters · filed 2015-03-26 | $2.92M 10-K · filed 2015-03-26 | $29.11M 10-K · filed 2014-03-27 | |||||||||||||
| 2013-09-30 | $804.00K 10-Q · filed 2014-11-13 | $1.55M derived: sum of 2 quarters · filed 2014-11-13 | $2.07M 10-Q · filed 2014-11-13 | $2.35M derived: sum of 4 quarters · filed 2014-11-13 | $28.26M 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $742.00K 10-Q · filed 2014-08-12 | $1.26M 10-Q · filed 2014-08-12 | $1.55M derived: sum of 3 quarters · filed 2014-08-12 | $2.28M derived: sum of 4 quarters · filed 2014-08-12 | $27.45M 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | $522.00K 10-Q · filed 2014-05-13 | $806.00K derived: sum of 2 quarters · filed 2014-05-13 | $1.54M derived: sum of 3 quarters · filed 2014-05-13 | $1.92M derived: sum of 4 quarters · filed 2014-05-13 | $26.71M 10-Q · filed 2013-05-09 | |||||||||||||
| 2012-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.02M derived: sum of 2 quarters · filed 2014-03-27 | $1.40M derived: sum of 3 quarters · filed 2014-03-27 | $1.77M 10-K · filed 2014-03-27 | $26.19M 10-K · filed 2013-03-14 | |||||||||||||
| 2012-09-30 | $732.00K 10-Q · filed 2013-11-14 | $1.12M derived: sum of 2 quarters · filed 2013-11-14 | $1.49M 10-Q · filed 2013-11-14 | $2.14M derived: sum of 4 quarters · filed 2013-11-14 | $25.91M 10-Q · filed 2012-11-13 | |||||||||||||
| 2012-06-30 | $385.00K 10-Q · filed 2013-08-14 | $754.00K 10-Q · filed 2013-08-14 | $1.41M derived: sum of 3 quarters · filed 2013-08-14 | $1.59M derived: sum of 4 quarters · filed 2013-08-14 | $25.17M 10-Q/A · filed 2012-08-29 | |||||||||||||
| 2012-03-31 | $369.00K 10-Q · filed 2013-05-09 | $1.03M derived: sum of 2 quarters · filed 2013-05-09 | $1.20M derived: sum of 3 quarters · filed 2013-05-09 | $1.79M derived: sum of 4 quarters · filed 2013-05-09 | $24.79M 10-Q · filed 2012-05-11 | |||||||||||||
| 2011-12-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $833.00K derived: sum of 2 quarters · filed 2013-03-14 | $1.42M derived: sum of 3 quarters · filed 2013-03-14 | $1.69M 10-K · filed 2013-03-14 | $24.42M 10-K · filed 2012-03-15 | |||||||||||||
| 2011-09-30 | $176.00K 10-Q · filed 2012-11-13 | $762.00K derived: sum of 2 quarters · filed 2012-11-13 | $1.03M 10-Q · filed 2012-11-13 | $1.12M derived: sum of 4 quarters · filed 2012-11-13 | $23.76M 10-Q · filed 2011-11-14 | |||||||||||||
| 2011-06-30 | $586.00K 10-Q/A · filed 2012-08-29 | -$586.00K 10-Q/A · filed 2011-09-07 | $856.00K 10-Q/A · filed 2012-08-29 | -$856.00K 10-Q/A · filed 2011-09-07 | $943.00K derived: sum of 3 quarters · filed 2012-08-29 | $1.31M derived: sum of 4 quarters · filed 2012-08-29 | -$23.59M 10-Q/A · filed 2011-09-07 | |||||||||||
| 2011-03-31 | $270.00K 10-Q · filed 2012-05-11 | $357.00K derived: sum of 2 quarters · filed 2012-05-11 | $728.00K derived: sum of 3 quarters · filed 2012-05-11 | $380.00K derived: sum of 4 quarters · filed 2012-05-11 | ||||||||||||||
| 2010-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $458.00K derived: sum of 2 quarters · filed 2012-03-15 | $110.00K derived: sum of 3 quarters · filed 2012-03-15 | $1.04M 10-K · filed 2012-03-15 | ||||||||||||||
| 2010-09-30 | $371.00K 10-Q · filed 2011-11-14 | $23.00K derived: sum of 2 quarters · filed 2011-11-14 | $958.00K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | -$348.00K 10-Q/A · filed 2011-09-07 | -$587.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |